- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.08. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.07. | NSE - Procaps Group, S.A. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| PROCAPS GROUP Aktie jetzt für 0€ handeln | |||||
| 14.07. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 13.05. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 09.04. | Procaps Group, S.A.: Procaps Group Secures $130 Million in Equity Investment and Completes Comprehensive Debt Restructuring, as New Investors Take Over Strategic Leadership | 138 | GlobeNewswire (Europe) | New Investors Take Over the Strategic Leadership as Headquarters Move to Bogotá, Marking the Start of a New Chapter of Growth, Execution, and Transformation under Enhanced Governance Company Accelerates... ► Artikel lesen | |
| 09.04. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 25.03. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 06.03. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 17.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 17.02.2025 | 1.634 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 17.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 17.02.2025ISIN NameCA00208E3077 ATI... ► Artikel lesen | |
| 04.02. | XFRA 9X1: AUSSETZUNG/SUSPENSION | 358 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPROCAPS GRP S.A.... ► Artikel lesen | |
| 03.02. | Procaps Group, S.A.: Procaps Group Receives Delisting Notice From Nasdaq | 422 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 03.01. | Procaps Group, S.A.: Procaps Group Receives Additional Delinquency Letter | 344 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 20.12.24 | Procaps Group, S.A.: Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates | 347 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 03.12.24 | Procaps Group, S.A.: Procaps Group Announces Financing, Shareholders Agreement and Board Updates | 235 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 29.11.24 | Pre-market Movers: Bolt Projects, Applied Therapeutics, Primega Group, Procaps Group, SKK Holdings | 1.132 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.25 A.M. ET).In the Green Bolt Projects Holdings, Inc. (BSLK) is up over 233%... ► Artikel lesen | |
| 16.11.24 | Procaps Group, S.A.: Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing | 380 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), announced today that, on November 13, 2024, the Company received... ► Artikel lesen | |
| 10.10.24 | Procaps Group, S.A.: Procaps Issues Shareholder Letter Update | 298 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 18.09.24 | Procaps Group, S.A.: Procaps Issues Shareholder Letter Update | 460 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 03.09.24 | Procaps Group, S.A.: Procaps Issues Shareholder Letter | 211 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical conglomerate... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,600 | 0,00 % | Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting | NASDAQ | TSX: ACB
EDMONTON, AB, Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada -based... ► Artikel lesen | |
| CANOPY GROWTH | 1,520 | -0,39 % | Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Apple, Canopy Growth & Alcon) | ||
| TILRAY BRANDS | 1,181 | -0,51 % | Kursziel 2 US-Dollar: Trumps Cannabis-Kurswechsel: Tilray-Aktie im Kursrausch | © Foto: Bebeto Matthews - APDie Cannabis-Branche in den USA steht vor einem möglichen Richtungswechsel - und Tilray könnte der große Profiteur sein. Das Analysehaus Jefferies hebt sein Kursziel an,... ► Artikel lesen | |
| TEVA | 15,800 | +0,32 % | Neues Abnehmmittel kommt!: Vorsicht Novo Nordisk & Eli Lilly - Teva bringt "Abnehm-Generika" auf US-Markt! | Novo Nordisk und Eli Lilly bekommen Konkurrenz: Teva steigt mit einem Generikum in den US-Markt für Abnehmpräparate ein. Mit der FDA-Zulassung steigt der israelische Pharmariese in den milliardenschweren... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 334,20 | -0,06 % | Maze Therapeutics referred to federal marketing regulators over challenge brought by Vertex | ||
| ARZNEIWERK AG VIDA | 0,150 | 0,00 % | EQS-HV: Arzneiwerk AG VIDA: Bekanntmachung der Einberufung zur Hauptversammlung am 04.09.2025 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG | EQS-News: Arzneiwerk AG VIDA
/ Bekanntmachung der Einberufung zur Hauptversammlung
Arzneiwerk AG VIDA: Bekanntmachung der Einberufung zur Hauptversammlung am 04.09.2025 in Berlin... ► Artikel lesen | |
| CRONOS GROUP | 2,210 | -0,45 % | Why Cronos Is Skyrocketing Again Today | ||
| VIATRIS | 9,010 | -0,16 % | Dividendenbekanntmachungen (22.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN AUSTRALIA EQUITY FUND INC US0030111035 0,12 USD 0,1033 EUR ACCO BRANDS CORPORATION US00081T1088 0,075 USD 0,0646 EUR ADM... ► Artikel lesen | |
| INCYTE | 71,68 | -0,91 % | Can Incyte Deliver on 447% EPS Forecasts and Pipeline Hype? | ||
| BAUSCH HEALTH | 6,308 | -0,35 % | Bausch Health Companies Inc.: Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025 | LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX)... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 36,140 | -0,88 % | XFRA ISI: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| CRESCO LABS | 1,260 | -1,02 % | Cresco Labs is still undervalued, this analyst says | ||
| ALNYLAM PHARMACEUTICALS | 385,50 | +1,05 % | Alnylam Pharmaceuticals, Inc.: Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial | - Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society of Cardiology Congress 2025 - - Zilebesiran Demonstrated Clinically Meaningful... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 25,200 | -1,56 % | Nektar Therapeutics Reports Second Quarter 2025 Financial Results | SAN FRANCISCO, Aug. 7, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2025.
Cash... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 1,846 | -0,65 % | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical | Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology
Accelerating multiple late-stage cancer therapies... ► Artikel lesen |
PROCAPS GROUP SA gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,340 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROCAPS GROUP SA finden Sie auf Wallstreet Online.